Your browser doesn't support javascript.
loading
Mineralocorticoid receptor inhibitor for long-standing central serous chorioretinopathy.
Suzuki, Azu; Takano, Yoji; Ando, Yasutaka; Ogawa, Junko; Ishida, Masahiro; Baba, Akiyasu; Imamura, Yutaka.
  • Suzuki A; Department of Ophthalmology, Kitasato Institute Hospital, Kitasato Univeristy, Tokyo, Japan.
  • Takano Y; Department of Ophthalmology, Kawasaki Municipal Ida Hospital, Kanagawa, Japan.
  • Ando Y; Department of Ophthalmology, Kitasato Institute Hospital, Kitasato Univeristy, Tokyo, Japan.
  • Ogawa J; Department of Ophthalmology, Kitasato Institute Hospital, Kitasato Univeristy, Tokyo, Japan.
  • Ishida M; Department of Ophthalmology, Teikyo University School of Medicine, University Hospital Mizonokuchi, Kanagawa, Japan.
  • Baba A; Department of Cardiology, Tokyo Dental College Ichikawa General Hospital, Chiba, Japan.
  • Imamura Y; Department of Ophthalmology, Kitasato Institute Hospital, Kitasato Univeristy, Tokyo, Japan.
Acta Ophthalmol ; 96(5): e662-e663, 2018 Aug.
Article en En | MEDLINE | ID: mdl-29671951
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Espironolactona / Coriorretinopatía Serosa Central Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Espironolactona / Coriorretinopatía Serosa Central Tipo de estudio: Diagnostic_studies / Observational_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Año: 2018 Tipo del documento: Article